News

The current data suggest that VB-201 has anti-inflammatory properties that are active against psoriasis; an ongoing Phase 2 efficacy and safety study is currently evaluating VB-201 for the

Silodyx is a new compound indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) and recently approved by the European Medicines Agency (EMA).

The data are expected to be presented during a poster session at the 29th Annual Scientific Meeting of the American Pain Society (APS), and are supported by PriCara,

The double-blind, placebo-controlled clinical study was conducted by researchers at the University of Cincinnati – College of Medicine. The study, entitled ‘Improved cognitive-cerebral function in older adults with

IncellDx claimed that the HPV OncoTect E6, E7 mRNA test provides quantification of the over expression of E6/E7 mRNA in each cell, as well as the total proportion

Bayer HealthCare Pharmaceuticals claimed that Natazia is the first and only oral contraceptive that contains an estrogen called estradiol valerate and a progestin called dienogest. Estradiol valerate is

Bayer said that Regorafenib is a potent oral multi-kinase inhibitor with a kinase inhibition profile targeting angiogenic, stromal and oncogenic receptor tyrosine kinases. The Correct (Patients with metastatic

Novartis will provide Polyphor with an upfront payment, research funding and milestone payments as candidate molecules progress through the drug discovery process, preclinical and clinical development and onto

Located in South Florida (USA), the new facility is expected to offer final assembly, labeling and packaging services to SHL’s pharmaceutical and biotech customers. SHL has been expanding